Abril-Carolina Mendoza-Lopez

Abril-Carolina Mendoza-Lopez

Auto-generated profile, based on publicly available information

Abril-Carolina Mendoza-Lopez

Department of Research, Hospital General de Mexico, Mexico City 06720, Mexico | Faculty of Medicine, Benemerita Universidad Autonoma de Puebla, Puebla 72410, Mexico

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2023 in Current Medical Imaging
Verified
Journal Article
Open access
PDF file
NSNicolas-De-Jesus Sanchez-Casas
Nicolas-De-Jesus Sanchez-Casas
LGLeslie Marisol González-Hermosillo
Leslie Marisol González-Hermosillo
AMAbril-Carolina Mendoza-Lopez
Abril-Carolina Mendoza-Lopez
ENElda-Lizeth Nava-Flores
Elda-Lizeth Nava-Flores
Ernesto Roldan-ValadezErnesto Roldan-Valadez
Ernesto Roldan-Valadez
Introduction: The concept of occult breast carcinoma (OBC) was first described in 1907 by Halsted, who described this type of breast cancer to arise from small, undetectable tumours in the breast that had already metastasized to the lymph nodes. Although the breast is the most likely site for the primary tumour, non-palpable breast cancer presenting as an axillary metastasis has been reported, but with a low frequency of less than 0.5% of all breast cancers. OBC represents a complex diagnostic and therapeutic dilemma. Considering its rarity, clinicopathological information is still limited. Case report: A 44-year-old patient presented to the emergency room with an extensive axillary mass as the first manifestation. Conventional evaluation of the breast with mammography and ultrasound was unremarkable. However, a breast MRI confirmed the presence of conglomerate axillary nodes. A supplementary whole-body PET-CT established the axillary conglomerate with a malignant behaviour with SUVmax of 19.3. The primary tumour was not detected in the breast tissue of the patient, confirming the diagnosis of OBC. Immunohistochemical results showed negative receptors for estrogen and progesterone. Conclusion: Although OBC is a rare diagnosis, its existence is a possibility in a patient with breast cancer. Mammography and breast ultrasound with unremarkable findings but with high clinical suspicion should be supplemented with additional imaging methods, such as MRI and PET-CT, emphasizing the appropriate pre-treatment evaluation.

1 December 2022 in The Journal of Rheumatology
Verified
Journal Article
Open access
PDF file
AMAbril-Carolina Mendoza-Lopez
Abril-Carolina Mendoza-Lopez
LGLeslie Marisol González-Hermosillo
Leslie Marisol González-Hermosillo
Ernesto Roldan-ValadezErnesto Roldan-Valadez
Ernesto Roldan-Valadez
"As the publishing sector continues to grow, the need to measure the quality of the produced science grows in parallel...." This assertion is extracted from a study that assessed the increment in the value of scientometric indexes when they were calculated using citations and open access publications in rheumatology journals.1